An interventional study of ACTIVE-Care Integrated Physical Activity-Based Supportive Care Program in Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Adolescent and Resilience, Psychological, sponsored by Selcuk University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 13 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-10-20.
Sponsored by Selcuk University · Not applicable, Interventional, and Supportive care
This study aimed to evaluate the effects of the ACTIVE-Care Integrated Physical Activity-Based Supportive Care Program on cancer-related fatigue, hope, and psychological resilience in adolescents with acute lymphoblastic leukemia (ALL). Seventy adolescents aged 13-16 years participated in a parallel-group randomized controlled trial. The intervention group received a six-week program integrating individualized physical activity with psychosocial support, while the control group received usual care. Outcomes were assessed at baseline and immediately after the six-week intervention.
This parallel-group randomized controlled trial used a pretest-posttest design to evaluate the effects of the ACTIVE-Care Integrated Physical Activity-Based Supportive Care Program on cancer-related fatigue, hope, and psychological resilience in adolescents with acute lymphoblastic leukemia (ALL).
Seventy adolescents aged 13-16 years were randomly assigned to the intervention group or the control group, with 35 participants in each group.
The intervention group received 12 supervised sessions delivered twice weekly over six weeks. The program integrated individualized physical activity with supportive care components addressing fatigue and energy management, goal setting, self-monitoring, positive feedback, coping, problem-solving, and social support.
The control group received usual care provided by the treating institution, without the ACTIVE-Care program or any additional study-specific intervention.
Cancer-related fatigue was assessed using the Assessment Scale for Fatigue in Pediatric Oncology Patients Aged 13-18 Years. Hope was assessed using the Children's Hope Scale (CHS), and psychological resilience was assessed using the Child and Youth Resilience Measure-12 (CYRM-12). Assessments were conducted at baseline, within one week before the intervention, and immediately after the six-week intervention.
9,610 studies on the registry are indexed under Neoplasms; 2,508 are open to participants now.
This study's enrollment of 70 is above the median of 50 across 7,429 interventional studies indexed under Neoplasms.
Browse Neoplasms studies →Selcuk University is the lead sponsor of 255 studies on the registry; 66 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants received the ACTIVE-Care Integrated Physical Activity-Based Supportive Care Program, comprising 12 supervised sessions delivered twice weekly over six weeks, in addition to usual care. The program integrated individualized physical activity with psychosocial support.
Behavioral: ACTIVE-Care Integrated Physical Activity-Based Supportive Care Program
Participants received usual care provided by the treating institution, without the ACTIVE-Care program or any additional study-specific intervention.
ACTIVE-Care was developed as a supportive care program integrating individualized physical activity with fatigue and energy management, goal setting, self-monitoring, coping, problem-solving, and social support strategies.
Change in Cancer-Related Fatigue - Assessment Scale for Fatigue in Pediatric Oncology Patients Aged 13-18 Years
Cancer-related fatigue is assessed using the Assessment Scale for Fatigue in Pediatric Oncology Patients Aged 13-18 Years. Total scores range from 32 to 160, with higher scores indicating lower fatigue and a better outcome, and lower scores indicating greater fatigue and a worse outcome. Change in total score is evaluated from baseline to immediately after the six-week intervention.
Time frame: Baseline (within 1 week before the intervention) and immediately after the 6-week intervention
Change in Hope - Children's Hope Scale (CHS)
Hope is assessed using the Children's Hope Scale, a six-item measure with each item rated from 1 to 6. Total scores range from 6 to 36, with higher scores indicating greater hope and a better outcome. Change in total score is evaluated from baseline to immediately after the six-week intervention.
Time frame: Baseline (within 1 week before the intervention) and immediately after the 6-week intervention
Change in Psychological Resilience - Child and Youth Resilience Measure-12 (CYRM-12)
Psychological resilience is assessed using the Child and Youth Resilience Measure-12, a 12-item measure with each item rated from 1 to 5. Total scores range from 12 to 60, with higher scores indicating greater psychological resilience and a better outcome. Change in total score is evaluated from baseline to immediately after the six-week intervention.
Time frame: Baseline (within 1 week before the intervention) and immediately after the 6-week intervention
Plan to share: No
No publications or documents are linked to this record.
Ran from Jul 2026 to primary completion in Jul 2026, 0 months.
Of 1,358 non-industry interventional studies with no phase under Neoplasms, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 71. This study's 0 months is below that.
Counting every sponsor, half of 1,404 studies reached it within 38 months; a quarter within 17 and three quarters within 71.
Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.